Corporate News

03-Sep-2026, 08:12

Kimia Biosciences Limited announced the re-appointment of Sameer Goel as director, liable to retire by rotation, and the appointment of Amulya Kumar Nayak as a Non-Executive, Non-Independent Director, and Reema Goyal and Avinash Prabhat as Non-Executive Independent Directors, all subject to member approval at the company’s 33rd Annual General Meeting. The board also approved remuneration for Cost Auditors M/s Mahesh Singh & Co., and authorized seeking member approval for increasing borrowing limits, creating mortgages, and making loans, guarantees, and securities, as per the Companies Act, 2013. Additionally, the company approved the 33rd AGM, scheduled for September 28, 2026, with a cut-off date for e-voting on September 21, 2026.